Morphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activation

Molecular Medicine

Volumn 12, Issue 11-12, 2006, Pages 284-290

  Messmer, Davorka ^a,d   Hatsukari, Ikusuke ^b   Hitosugi, Naoko ^b   Schmidt Wolf, Ingo G H ^c   Singhal, Pravin C ^b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; DELTA OPIATE RECEPTOR; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; KAPPA OPIATE RECEPTOR; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; MORPHINE; MU OPIATE RECEPTOR; NALOXONE;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DENDRITIC CELLS; HUMANS; IMIDAZOLES; IMMUNOSUPPRESSION; INTERLEUKIN-10; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MONOCYTES; MORPHINE; OPIOID-RELATED DISORDERS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; T-LYMPHOCYTES;

EID: 33947615694     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2006-00043.Messmer     Document Type: Article

References (45)

1. Rouveix B. (1992) Opiates and immune function: consequences on infectious diseases with special reference to AIDS. Therapie 47:503-12.
2. Sibinga NE, Goldstein A. (1988) Opioid peptides and opioid receptors in cells of the immune system. Annu. Rev. Immunol. 6:219-49.
3. Weigent DA, Blalock JE. (1987) Interactions between the neuroendocrine and immune systems: common hormones and receptors. Immunol. Rev. 100:79-108.
4. Vallejo R, de Leon-Casasola O, Benyamin R. (2004) Opioid therapy and immunosuppression: a review. Am. J. Ther. 11:354-65.
5. Roy S, Loh HH. (1996) Effects of opioids on the immune system. Neurochem. Res. 21:1375-86.
6. Eisenstein TK, Hilburger ME. (1998) Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J. Neuroimmunol. 83:36-44.
7. Bryant HU, Bernton EW, Holaday JW. (1987) Immunosuppressive effects of chronic morphine treatment in mice. Life Sci. 41:1731-8.
8. Liang-Suo J, Gomez-Flores R, Weber RJ. (2002) Immunosuppression induced by central action of morphine is not blocked by mifepristone (RU 486). Life Sci. 71:2595-602.
9. Luza J. (1992) Effect of morphine on phagocytic activity of the polymorphonuclears and monocytes. Acta Univ. Palacki Olonmc. Fac. Med. 134:47-50.
10. Liu Y, Blackbourn DJ, Chuang LF, Killam KF Jr, Chuang RY. (1992) Effects of in vivo and in vitro administration of morphine sulfate upon rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis. J. Pharmacol. Exp. Ther. 263:533-9.
11. Donahoe RM, et al. (2001) Effects of morphine on T-cell recirculation in rhesus monkeys. Adv. Exp. Med. Biol. 493:89-101.
12. Bryant HU, Bernton EW, Holaday JW. (1988) Morphine pellet-induced immunomodulation in mice: temporal relationships. J. Pharmacol. Exp. Ther. 245:913-20.
13. Singhal P, Kapasi A, Reddy K, Franki N. (2001) Opiates promote T cell apoptosis through JNK and caspase pathway. Adv. Exp. Med. Biol. 493:127-35.
14. Bhat RS, Bhaskaran M, Mongia A, Hitosugi N, Singhal PC. (2004) Morphine-induced macrophage apoptosis: oxidative stress and strategies for modulation. J. Leukoc. Biol. 75:1131-8.
15. Malik AA, Radhakrishnan N, Reddy K, Smith AD, Singhal PC. (2002) Morphine-induced macrophage apoptosis modulates migration of macrophages: use of in vitro model of urinary tract infection. J. Endourol 16:605-10.
16. Bhaskaran M, et al. (2001) Morphine-induced degradation of the host defense barrier: role of macrophage injury. J. Infect. Dis. 184:1524-31.
17. Singhal PC, Sharma P, Kapasi AA, Reddy K, Franki N, Gibbons N. (1998) Morphine enhances macrophage apoptosis. J. Imnmnol. 160:1886-93.
18. Gomez-Flores R, Suo JL, Weber RJ. (1999) Suppression of splenic macrophage functions following acute morphine action in the rat mesencephalon periaqueductal gray. Brain Behav. Immun. 13:212-24.
19. Roy S, Charboneau RG, Barke RA. (1999) Morphine synergizes with lipopolysaccharide in a chronic endotoxemia model. J. Neuroimmunol. 95:107-14.
20. Eisenstein TK, Rogers TJ, Meissler JJ Jr, Adler MW, Hilburger ME. (1998) Morphine depresses macrophage numbers and function in mouse spleens. Adv. Exp. Med. Biol. 437:33-41.
21. Banchereau J, Steinman RM. (1998) Dendritic cells and the control of immunity. Nature 392:245-52.
22. Asahina A, Hosoi J, Grabbe S, Granstein RD. (1995) Modulation of Langerhans cell function by epidermal nerves. J. Allergy Clin. Immunol. 96:1178-82.
23. Asahina A, et al. (1995) Specific induction of cAMP in Langerhans cells by calcitonin gene-related peptide: relevance to functional effects. Proc. Natl. Acad. Sci. U. S. A. 92:8323-7.
24. Marriott I, Mason MJ, Elhofy A, Bost KL. (2000) Substance P activates NF-kappaB independent of elevations in intracellular calcium in murine macrophages and dendritic cells. J. Neuroimmunol. 102:163-71.
25. Delneste Y, et al. (1999) Vasoactive intestinal peptide synergizes with TNF-alpha in inducing human dendritic cell maturation. J. Immunol. 163:3071-5.
26. Kirst A, Wack C, Lutz WK, Eggert A, Kampgen E, Fischer WH. (2002) Expression of functional kappa-opioid receptors on murine dendritic cells. Immunol. Lett. 84:41-8.
27. Makarenkova VP, et al. (2001) Identification of delta- and mu-type opioid receptors on human and murine dendritic cells. J. Neuroimmunol. 117:68-77.
28. Reisine T, Brownstein MJ. (1994) Opioid and cannabinoid receptors. Curr. Opin. Neurobiol. 4:406-12.
29. Taga K, Tosato C. (1992) 1L-10 inhibits human T cell proliferation and 1L-2 production. J. Immunol. 148:1143-8.
30. Esche C, et al. (1999) Murine dendritic cells express functional delta-type opioid receptors. Ann. N. Y. Acad. Sci. 885:387-90.
31. Gilliet M, et al. (2002) The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 195:953-8.
32. Basu S, Srivastava P. (2005) Immunological role of neuronal receptor vanilloid receptor 1 expressed on dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 102:5120-5.
33. McBride JM, Jung T, de Vries JE, Aversa G. (2002) 1L-10 alters DC function via modulation of cell surface molecules resulting in impaired T-cell responses. Cell Immunol. 215:162-72.
34. Corinti S, Albanesi C, la Sala A, Pastore S, Girolomoni G. (2001) Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 166:4312-8.
35. Xia CQ, Kao KJ. (2003) Suppression of interleukin-12 production through endogenously secreted interleukin-10 in activated dendritic cells: involvement of activation of extracellular signal-regulated protein kinase. Scand. J. Immunol. 58, 23-32.
36. Trinchieri G. (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-76.
37. Peng X, Mosser DM, Adler MW, Rogers TJ, Meissler JJ Jr, Eisenstein TK. (2000) Morphine enhances interleukin-12 and the production of other pro-inflammatory cytokines in mouse peritoneal macrophages. J. Leukoc. Biol. 68:723-8.
38. Zurawski G, Benedik M, Kamb BJ, Abrams JS, Zurawski SM, Lee FD. (1986) Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis. Science 232:772-5.
39. Linner KM, Quist HE, Sharp BM. (1995) Metenkephalin-containing peptides encoded by proenkephalin A mRNA expressed in activated murine thymocytes inhibit thymocyte proliferation. J. Immunol. 154:5049-60.
40. Cabot PJ, Carter L, Schafer M, Stein C. (2001) Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory pain. Pain 93:207-12.
41. Gately MK, et al. (1998) The interleukin-12/ interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16:495-521.
42. Ulevitch RJ, Tobias PS. (1995) Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:437-57.
43. Falcone M, Sarvetnick N. (1999) Cytokines that regulate autoimmune responses. Curr. Opin. Immmunol. 11:670-6.
44. Li W, et al. (2001) II-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance. J. Immunol. 166:5619-28.
45. Finkelman FD, et al. (1997) Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu. Rev. Immunol. 15:505-33.